placebo: be used in drug trials

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents effect
Weight: 0.53
, thing
Weight: 0.50
, act
Weight: 0.48
, band
Weight: 0.48
, drug
Weight: 0.47
Siblings vancomycin
Weight: 0.33
, ibuprofen
Weight: 0.32
, bupropion
Weight: 0.32
, warfarin
Weight: 0.32
, metronidazole
Weight: 0.32

Related properties

Property Similarity
be used in drug trials 1.00
be used in trials 0.94
be used in clinical trials 0.89
be included in trials 0.89
be used in double-blind drug test 0.88
be used in drug test 0.88
be included in clinical trials 0.87

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.82
Similarity weight: 1.00
Evidence: 0.79
Plausible(placebo, be used in drug trials)
Evidence: 0.85
¬ Salient(placebo, be used in drug trials)

Similarity expansion

0.73
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.94
Evidence: 0.82
Typical(placebo, be used in drug trials)
Evidence: 0.45
¬ Typical(placebo, be used in trials)
0.71
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.94
Evidence: 0.85
Salient(placebo, be used in drug trials)
Evidence: 0.74
¬ Salient(placebo, be used in trials)
0.66
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.88
Evidence: 0.85
Salient(placebo, be used in drug trials)
Evidence: 0.82
¬ Salient(placebo, be used in drug test)
0.66
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.89
Evidence: 0.85
Salient(placebo, be used in drug trials)
Evidence: 0.93
¬ Salient(placebo, be used in clinical trials)
0.66
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.88
Evidence: 0.82
Typical(placebo, be used in drug trials)
Evidence: 0.68
¬ Typical(placebo, be used in drug test)
0.66
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.89
Evidence: 0.85
Salient(placebo, be used in drug trials)
Evidence: 0.89
¬ Salient(placebo, be included in trials)
0.65
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.89
Evidence: 0.82
Typical(placebo, be used in drug trials)
Evidence: 0.81
¬ Typical(placebo, be included in trials)
0.64
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.94
Evidence: 0.79
Plausible(placebo, be used in drug trials)
Evidence: 0.92
¬ Plausible(placebo, be used in trials)
0.64
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.88
Evidence: 0.85
Salient(placebo, be used in drug trials)
Evidence: 0.99
¬ Salient(placebo, be used in double-blind drug test)
0.64
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.87
Evidence: 0.85
Salient(placebo, be used in drug trials)
Evidence: 0.97
¬ Salient(placebo, be included in clinical trials)
0.64
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.89
Evidence: 0.82
Typical(placebo, be used in drug trials)
Evidence: 0.91
¬ Typical(placebo, be used in clinical trials)
0.64
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.88
Evidence: 0.79
Plausible(placebo, be used in drug trials)
Evidence: 0.70
¬ Plausible(placebo, be used in drug test)
0.62
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.89
Evidence: 0.79
Plausible(placebo, be used in drug trials)
Evidence: 0.88
¬ Plausible(placebo, be used in clinical trials)
0.62
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.88
Evidence: 0.82
Typical(placebo, be used in drug trials)
Evidence: 0.97
¬ Typical(placebo, be used in double-blind drug test)
0.61
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.87
Evidence: 0.82
Typical(placebo, be used in drug trials)
Evidence: 0.97
¬ Typical(placebo, be included in clinical trials)
0.61
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.87
Evidence: 0.62
Remarkable(placebo, be used in drug trials)
Evidence: 0.48
¬ Remarkable(placebo, be included in clinical trials)
0.60
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.89
Evidence: 0.79
Plausible(placebo, be used in drug trials)
Evidence: 0.98
¬ Plausible(placebo, be included in trials)
0.60
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.88
Evidence: 0.79
Plausible(placebo, be used in drug trials)
Evidence: 0.94
¬ Plausible(placebo, be used in double-blind drug test)
0.59
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.89
Evidence: 0.62
Remarkable(placebo, be used in drug trials)
Evidence: 0.58
¬ Remarkable(placebo, be included in trials)
0.59
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.87
Evidence: 0.79
Plausible(placebo, be used in drug trials)
Evidence: 1.00
¬ Plausible(placebo, be included in clinical trials)
0.58
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.89
Evidence: 0.62
Remarkable(placebo, be used in drug trials)
Evidence: 0.62
¬ Remarkable(placebo, be used in clinical trials)
0.57
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.94
Evidence: 0.62
Remarkable(placebo, be used in drug trials)
Evidence: 0.76
¬ Remarkable(placebo, be used in trials)
0.56
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.88
Evidence: 0.62
Remarkable(placebo, be used in drug trials)
Evidence: 0.66
¬ Remarkable(placebo, be used in double-blind drug test)
0.54
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.88
Evidence: 0.62
Remarkable(placebo, be used in drug trials)
Evidence: 0.74
¬ Remarkable(placebo, be used in drug test)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.85
Salient(placebo, be used in drug trials)
Evidence: 0.82
¬ Typical(placebo, be used in drug trials)
Evidence: 0.62
¬ Remarkable(placebo, be used in drug trials)

Typical implies Plausible

0.40
Rule weight: 0.48
Evidence weight: 0.83
Similarity weight: 1.00
Evidence: 0.79
Plausible(placebo, be used in drug trials)
Evidence: 0.82
¬ Typical(placebo, be used in drug trials)